This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.08% per year. These returns cover a period from January 1, 1988 through May 6, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
When Does Market Timing Actually Work? - March 16, 2020
by Zacks Equity Research
In the long-run, does consistent market timing really matter to be a successful investor?
Timing the Market, Is it Possible? - February 26, 2020
by Zacks Equity Research
In the long-run, does consistent market timing really matter to be a successful investor?
When Does Market Timing Actually Work? - February 05, 2020
by Zacks Equity Research
Have you ever dreamed of being that one in a million investor who has the talent to perfectly time the markets?
How to Time the Markets Like an Investing Pro - January 17, 2020
by Zacks Equity Research
In the long-run, does consistent market timing really matter to be a successful investor?
The Market Timing Secrets No One Talks About - December 24, 2019
by Zacks Equity Research
Is the ability to time the markets more of a data-driven science or a 'gut - feeling' art?
Simple Market Timing Strategies That Work - December 04, 2019
by Zacks Equity Research
Is the ability to time the markets more of a data-driven science or a 'gut - feeling' art?
The Truth About Market Timing - November 14, 2019
by Zacks Equity Research
In the long-run, does consistent market timing really matter to be a successful investor?
The Truth About Market Timing - October 24, 2019
by Zacks Equity Research
In the long-run, does consistent market timing really matter to be a successful investor?
When Does Market Timing Actually Work? - October 03, 2019
by Zacks Equity Research
Is the ability to time the markets more of a data-driven science or a 'gut - feeling' art?
The Truth About Market Timing - September 13, 2019
by Zacks Equity Research
Is the ability to time the markets more of a data-driven science or a 'gut - feeling' art?
Yes, You Can Time the Market. Find out How - August 26, 2019
by Zacks Equity Research
Have you ever dreamed of being that one in a million investor who has the talent to perfectly time the markets?
Simple Market Timing Strategies That Work - August 05, 2019
by Zacks Equity Research
In the long-run, does consistent market timing really matter to be a successful investor?
Moving Average Crossover Alert: Champions Oncology
by Zacks Equity Research
Champions Oncology, Inc. (CSBR) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front.
New Strong Sell Stocks for April 16th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today
New Strong Sell Stocks for April 1st
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today
New Strong Sell Stocks for March 27th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
New Strong Sell Stocks for March 25th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today.
Champions Oncology (CSBR) Q3 Earnings: What's in Store?
by Zacks Equity Research
During Champions Oncology's (CSBR) third-quarter fiscal 2019 conference call, investor focus will be on the company's progress with its Ex Vivo platform and services.
Weakness Seen in Champions Oncology (CSBR) Estimates: Should You Stay Away?
by Zacks Equity Research
Champions Oncology (CSBR) has witnessed a significant price decline in the past four weeks, and is seeing negative earnings estimate revisions as well.
Champions Oncology (CSBR) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Champions Oncology (CSBR) closed at $10.39, marking a +0.39% move from the previous day.
Champions Oncology (CSBR) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Champions Oncology (CSBR) closed the most recent trading day at $12.41, moving -1.43% from the previous trading session.
Champions Oncology (CSBR) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Champions Oncology (CSBR) closed at $13.43 in the latest trading session, marking a +1.13% move from the prior day.
Champions Oncology Sees Hammer Chart Pattern: Time to Buy?
by Zacks Equity Research
Champions Oncology has been struggling lately, but the selling pressure may be coming to an end soon.
Has Champions Oncology (CSBR) Outpaced Other Medical Stocks This Year?
by Zacks Equity Research
Is (CSBR) Outperforming Other Medical Stocks This Year?
Champions Oncology (CSBR) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Champions Oncology (CSBR) closed at $12.21 in the latest trading session, marking a +0.58% move from the prior day.